Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-20

Clinical Trial Update: The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia

View source ↗

Summary

A completed clinical trial evaluating the combination of a systematized behavioural modification education program (SyBeMeP) with desmopressin (DDAVP) for noctu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DDAVP (desmopressin acetate)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Nocturia | Status: COMPLETED